Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma

The aim of this study is to evaluate the efficacy of insulin‐like growth factor 1 receptor (IGF‐1R) inhibitor Linsitinib, in esophageal squamous cell carcinoma (ESCC), and to characterize special biomarker to screen Linsitinib‐sensitive patients as well as explore the molecular‐resistant mechanism t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Junzhou, Chen, Kaiyan, Zhang, Fanrong, Jin, Jiaoyue, Zhang, Nan, Li, Dan, Ying, Lisha, Chen, Wei, Yu, Herbert, Mao, Weimin, Su, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463077/
https://www.ncbi.nlm.nih.gov/pubmed/28440057
http://dx.doi.org/10.1002/cam4.1068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463077/
https://www.ncbi.nlm.nih.gov/pubmed/28440057
http://dx.doi.org/10.1002/cam4.1068

Ejemplares similares